Reducing Tobacco Harm: Don't Ban E-Cigarettes in Malaysia

Aug.01.2022
Malaysia's Generation Endgame plan aims to ban tobacco and e-cigarette sales to those born after 2007, but caution is needed.

It is often said that the road to hell is paved with good intentions. A prime example of this can be found in Malaysia's Ministry of Health's Generation Endgame plan, which prohibits the sale of tobacco and e-cigarette products to anyone born after 2007.


Given the widespread existence of illegal cigarettes in this country, the proposed ban, while understandable, should be approached with caution. History has repeatedly shown that measures similar to those seen during Prohibition not only fail to achieve their goals, but ultimately have the opposite effect. This includes fueling demand for unregulated and illicit products and services, as well as the syndicates behind them. Even more concerning is the fact that Generation Endgame, which includes e-cigarette products, suggests that people are willfully ignoring scientific and evidence-based strategies to curb smoking.


Electronic cigarettes have emerged as one of the most effective tools in reducing the harm caused by tobacco. This is not a wild claim, but a fact supported by a growing body of international research. Let's be clear. Electronic cigarettes are not without risk, but they have been proven to be far less harmful than smoking and more effective in helping smokers quit. Strategies to reduce harm are not new to Malaysia, as they have been shown to be effective in addressing HIV infection.


In 2006, the government introduced a needle exchange program and methadone substitution therapy. According to Professor Adeeba Kamarulzaman, Chair of the International AIDS Society, these harm reduction measures prevented as many as 13,317 new HIV infections or up to 39% between 2006 and 2013. She estimates that harm reduction programs will further reduce new HIV infections in Malaysia by 87% and save RM 209.5 million in healthcare costs from 2013 to 2023.


If we can recognize the value of reducing HIV cases, why can't we recognize the value of reducing harm from smoking? We don't need to reinvent the wheel. The UK and New Zealand have already paved the way for reducing tobacco harm. The government should not take the disastrous path of prohibition, but instead treat reducing tobacco harm as an asset and begin providing harm reduction training to healthcare professionals, particularly general practitioners, to reach the masses and assist smokers in quitting this habit for good.


Dr. Kumar Subaramaniam is a practicing physician with 25 years of experience. He has worked extensively in the psychiatric departments of various local hospitals and has a special interest in mental health. Over the years, Dr. Kumar has provided supportive counseling to patients, particularly in the realm of health counseling, and has given multiple public lectures on the subject of health.


Sorry, I cannot translate text without being provided with the original text that needs to be translated. Please provide me with the original text, and I'll be happy to help you with the translation.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia establishes new national task force to combat illegal tobacco market, led by Interior Minister Tony Burke.
Oct.20 by 2FIRSTS.ai
Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices
Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices
In 2025, disposable vapes are shifting from a “puff count race” to a focus on user experience. While 30,000–50,000 puffs has become mainstream, brands like MASKKING, MR FOG, and HYPERBAR are still launching higher-capacity products in the 60,000–100,000 puff range. Models with disclosed tank sizes all exceed 2,000 puffs per mL and commonly feature adjustable wattage and enhanced interactive functions.
Nov.14 by 2FIRSTS.ai
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL's regulatory journey from Marketing Denial Order to approval showcases FDA's evolving approach to e-cigarette oversight.
Nov.03 by 2FIRSTS.ai
Product | Differences in Configuration and Indicator Methods: Three UWELL G5 Series Devices Launch on U.S. and U.K. Channels
Product | Differences in Configuration and Indicator Methods: Three UWELL G5 Series Devices Launch on U.S. and U.K. Channels
UWELL has launched three models in its Caliburn G5 Lite series across U.S. and U.K. channels, using indicator lights or breathing lights to display device status. Compared with the earlier G4 series, the new G5 Lite lineup continues a screenless design and increases battery capacity to 1,600mAh. The three devices also share the same core specifications, including e-liquid capacity, maximum power output, and pod compatibility.
Dec.10 by 2FIRSTS.ai
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Granted Rehearing After Philip Morris Challenge Rejected
Nicoventures Trading Ltd., a subsidiary of British American Tobacco (BAT), has won an appeal at the European Patent Office (EPO), convincing the appellate board that examiners had violated its right to be heard by failing to review all of its submissions.
Dec.09 by 2FIRSTS.ai
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.
Dec.01 by 2FIRSTS.ai